
Juvena W. Loo
Examiner (ID: 18974, Phone: (571)270-1974 , Office: P/2473 )
| Most Active Art Unit | 2473 |
| Art Unit(s) | 2473, 2616, 2416, 2609 |
| Total Applications | 547 |
| Issued Applications | 438 |
| Pending Applications | 1 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16523716
[patent_doc_number] => 20200397796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => METHODS OF TREATMENT OF CANCER COMPRISING CHK1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/975686
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -124
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975686 | METHODS OF TREATMENT OF CANCER COMPRISING CHK1 INHIBITORS | Feb 25, 2019 | Abandoned |
Array
(
[id] => 16492357
[patent_doc_number] => 10858382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Allyl phosphine complexes of palladium and their use in catalysis
[patent_app_type] => utility
[patent_app_number] => 16/284841
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19502
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284841 | Allyl phosphine complexes of palladium and their use in catalysis | Feb 24, 2019 | Issued |
Array
(
[id] => 17640589
[patent_doc_number] => 20220168327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => Compounds for Treating and Preventing Net Associated Complications
[patent_app_type] => utility
[patent_app_number] => 17/430756
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430756 | Compounds for treating and preventing net associated complications | Feb 24, 2019 | Issued |
Array
(
[id] => 18171741
[patent_doc_number] => 11571433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Methods for treating memory impairment and cognitive dysfunction
[patent_app_type] => utility
[patent_app_number] => 16/975129
[patent_app_country] => US
[patent_app_date] => 2019-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6330
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975129 | Methods for treating memory impairment and cognitive dysfunction | Feb 23, 2019 | Issued |
Array
(
[id] => 14467563
[patent_doc_number] => 20190185424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/282894
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282894 | Potent and selective inhibitors of monoamine transporters; method of making; and use thereof | Feb 21, 2019 | Issued |
Array
(
[id] => 16718552
[patent_doc_number] => 20210085699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => COMBINATION THERAPIES FOR TREATING CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/971887
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971887 | COMBINATION THERAPIES FOR TREATING CANCERS | Feb 20, 2019 | Abandoned |
Array
(
[id] => 16261224
[patent_doc_number] => 10752643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Tunable rare-earth fcu-metal-organic frameworks
[patent_app_type] => utility
[patent_app_number] => 16/280504
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 77
[patent_no_of_words] => 11067
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280504 | Tunable rare-earth fcu-metal-organic frameworks | Feb 19, 2019 | Issued |
Array
(
[id] => 16261224
[patent_doc_number] => 10752643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Tunable rare-earth fcu-metal-organic frameworks
[patent_app_type] => utility
[patent_app_number] => 16/280504
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 77
[patent_no_of_words] => 11067
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280504 | Tunable rare-earth fcu-metal-organic frameworks | Feb 19, 2019 | Issued |
Array
(
[id] => 16261224
[patent_doc_number] => 10752643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Tunable rare-earth fcu-metal-organic frameworks
[patent_app_type] => utility
[patent_app_number] => 16/280504
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 77
[patent_no_of_words] => 11067
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280504 | Tunable rare-earth fcu-metal-organic frameworks | Feb 19, 2019 | Issued |
Array
(
[id] => 14438849
[patent_doc_number] => 20190177297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/280512
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280512 | 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | Feb 19, 2019 | Issued |
Array
(
[id] => 16261224
[patent_doc_number] => 10752643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Tunable rare-earth fcu-metal-organic frameworks
[patent_app_type] => utility
[patent_app_number] => 16/280504
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 77
[patent_no_of_words] => 11067
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280504 | Tunable rare-earth fcu-metal-organic frameworks | Feb 19, 2019 | Issued |
Array
(
[id] => 16876790
[patent_doc_number] => 11026910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => a- and g-truxillic acid derivatives and pharmaceutical compositions thereof
[patent_app_type] => utility
[patent_app_number] => 16/276920
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 33
[patent_no_of_words] => 18977
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/276920 | a- and g-truxillic acid derivatives and pharmaceutical compositions thereof | Feb 14, 2019 | Issued |
Array
(
[id] => 20356223
[patent_doc_number] => 12472202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Compositions and their use in the treatment of endometriosis and pain
[patent_app_type] => utility
[patent_app_number] => 16/968696
[patent_app_country] => US
[patent_app_date] => 2019-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22134
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968696 | Compositions and their use in the treatment of endometriosis and pain | Feb 8, 2019 | Issued |
Array
(
[id] => 16468160
[patent_doc_number] => 20200369697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS
[patent_app_type] => utility
[patent_app_number] => 16/966369
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966369 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | Feb 7, 2019 | Abandoned |
Array
(
[id] => 16246095
[patent_doc_number] => 10745436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Neuroactive steroids, compositions, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/269779
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31912
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269779
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269779 | Neuroactive steroids, compositions, and uses thereof | Feb 6, 2019 | Issued |
Array
(
[id] => 14406539
[patent_doc_number] => 20190169113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Ketamine Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/269015
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269015 | Ketamine Derivatives | Feb 5, 2019 | Abandoned |
Array
(
[id] => 17648487
[patent_doc_number] => 11351188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Folic compositions and methods for treatment of diabetic neuropathies
[patent_app_type] => utility
[patent_app_number] => 16/264609
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5625
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264609 | Folic compositions and methods for treatment of diabetic neuropathies | Jan 30, 2019 | Issued |
Array
(
[id] => 14649355
[patent_doc_number] => 20190231806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Metformin Compositions and Methods for Treatment of Diabetes
[patent_app_type] => utility
[patent_app_number] => 16/264595
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264595 | Metformin compositions and methods for treatment of diabetes | Jan 30, 2019 | Issued |
Array
(
[id] => 16621479
[patent_doc_number] => 20210040132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => NOVEL COMPOUND FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967092
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967092 | Compound for preventing or treating neurodegenerative disease and application thereof | Jan 28, 2019 | Issued |
Array
(
[id] => 16540967
[patent_doc_number] => 20200407380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => ORGANOMETALLIC COMPOUNDS AND THIN FILM USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/968492
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968492 | Organometallic compounds and thin film using same | Jan 24, 2019 | Issued |